BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang M, Thurmond RL, Dunford PJ. The histamine H4 receptor: A novel modulator of inflammatory and immune disorders. Pharmacology & Therapeutics 2007;113:594-606. [DOI: 10.1016/j.pharmthera.2006.11.008] [Cited by in Crossref: 74] [Cited by in F6Publishing: 63] [Article Influence: 4.9] [Reference Citation Analysis]
Number Citing Articles
1 Sahlholm K, Nilsson J, Marcellino D, Fuxe K, Århem P. Electrophysiology-based analysis of human histamine H4 receptor pharmacology using GIRK channel coupling in Xenopus oocytes. European Journal of Pharmacology 2008;591:52-8. [DOI: 10.1016/j.ejphar.2008.06.029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
2 Kamińska K, Ziemba J, Ner J, Schwed JS, Łażewska D, Więcek M, Karcz T, Olejarz A, Latacz G, Kuder K, Kottke T, Zygmunt M, Sapa J, Karolak-wojciechowska J, Stark H, Kieć-kononowicz K. (2-Arylethenyl)-1,3,5-triazin-2-amines as a novel histamine H4 receptor ligands. European Journal of Medicinal Chemistry 2015;103:238-51. [DOI: 10.1016/j.ejmech.2015.08.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
3 Savall BM, Meduna SP, Venable J, Wei J, Smith RC, Hack MD, Thurmond RL, Mcgovern P, Edwards JP. The effect of pKa on pyrimidine/pyridine-derived histamine H4 ligands. Bioorganic & Medicinal Chemistry Letters 2014;24:5489-92. [DOI: 10.1016/j.bmcl.2014.10.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Koenig JR, Liu H, Drizin I, Witte DG, Carr TL, Manelli AM, Milicic I, Strakhova MI, Miller TR, Esbenshade TA, Brioni JD, Cowart M. Rigidified 2-aminopyrimidines as histamine H4 receptor antagonists: Effects of substitution about the rigidifying ring. Bioorganic & Medicinal Chemistry Letters 2010;20:1900-4. [DOI: 10.1016/j.bmcl.2010.01.131] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
5 Kaneko H, Ye F, Ijima R, Kachi S, Kato S, Nagaya M, Higuchi A, Terasaki H. Histamine H4 receptor as a new therapeutic target for choroidal neovascularization in age-related macular degeneration. Br J Pharmacol 2014;171:3754-63. [PMID: 24787705 DOI: 10.1111/bph.12737] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
6 Nordemann U, Wifling D, Schnell D, Bernhardt G, Stark H, Seifert R, Buschauer A. Luciferase reporter gene assay on human, murine and rat histamine H4 receptor orthologs: correlations and discrepancies between distal and proximal readouts. PLoS One 2013;8:e73961. [PMID: 24023919 DOI: 10.1371/journal.pone.0073961] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
7 Ravhe IS, Krishnan A, Manoj N. Evolutionary history of histamine receptors: Early vertebrate origin and expansion of the H3-H4 subtypes. Mol Phylogenet Evol 2021;154:106989. [PMID: 33059072 DOI: 10.1016/j.ympev.2020.106989] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Zampeli E, Tiligada E. The role of histamine H4 receptor in immune and inflammatory disorders. Br J Pharmacol 2009;157:24-33. [PMID: 19309354 DOI: 10.1111/j.1476-5381.2009.00151.x] [Cited by in Crossref: 199] [Cited by in F6Publishing: 172] [Article Influence: 15.3] [Reference Citation Analysis]
9 Engelhardt H, Schultes S, de Graaf C, Nijmeijer S, Vischer HF, Zuiderveld OP, Dobler J, Stachurski K, Mayer M, Arnhof H, Scharn D, Haaksma EE, de Esch IJ, Leurs R. Bispyrimidines as potent histamine H(4) receptor ligands: delineation of structure-activity relationships and detailed H(4) receptor binding mode. J Med Chem 2013;56:4264-76. [PMID: 23668417 DOI: 10.1021/jm301886t] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
10 Yamamoto K, Okui R, Yamatodani A. Effects of a histamine H4 receptor antagonist on cisplatin-induced anorexia in mice. Neurosci Lett 2018;676:103-7. [PMID: 29655943 DOI: 10.1016/j.neulet.2018.04.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Hartwig C, Munder A, Glage S, Wedekind D, Schenk H, Seifert R, Neumann D. The histamine H4 -receptor (H4 R) regulates eosinophilic inflammation in ovalbumin-induced experimental allergic asthma in mice. Eur J Immunol 2015;45:1129-40. [PMID: 25501767 DOI: 10.1002/eji.201445179] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
12 Łażewska D, Karolak-wojciechowska J, Kolesińska B, Kamiński Z, Kieć-kononowicz K. Convenient way of synthesis and crystal structure of 1-[(5-chloro-1H-indol-2-yl)carbonyl]-4-methylpiperazine, a histamine H4 receptor antagonist. Heterocyclic Communications 2011;17. [DOI: 10.1515/hc.2011.035] [Reference Citation Analysis]
13 Qin D, Zhang H, Wang J, Hong Z. Histamine H4 receptor gene polymorphisms: a potential contributor to Meniere disease. BMC Med Genomics 2019;12:71. [PMID: 31133025 DOI: 10.1186/s12920-019-0533-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
14 Meng J, Ma X, Li M, Jia M, Luo X. Histamine H4 receptors regulate ACTH release in AtT-20 cells. European Journal of Pharmacology 2008;587:336-8. [DOI: 10.1016/j.ejphar.2008.03.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
15 Tongsook C, Niederhauser J, Kronegger E, Straganz G, Macheroux P. Leucine 208 in human histamine N-methyltransferase emerges as a hotspot for protein stability rationalizing the role of the L208P variant in intellectual disability. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2017;1863:188-99. [DOI: 10.1016/j.bbadis.2016.10.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
16 Richter H, Freichel C, Huwyler J, Nakagawa T, Nettekoven M, Plancher J, Raab S, Roche O, Schuler F, Taylor S, Ullmer C, Wiegand R. Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold. Bioorganic & Medicinal Chemistry Letters 2010;20:5713-7. [DOI: 10.1016/j.bmcl.2010.08.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
17 Savall BM, Chavez F, Tays K, Dunford PJ, Cowden JM, Hack MD, Wolin RL, Thurmond RL, Edwards JP. Discovery and SAR of 6-alkyl-2,4-diaminopyrimidines as histamine H₄ receptor antagonists. J Med Chem 2014;57:2429-39. [PMID: 24495018 DOI: 10.1021/jm401727m] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
18 Kiss R, Keseru˝ GM. Histamine H4 receptor ligands and their potential therapeutic applications. Expert Opinion on Therapeutic Patents 2009;19:119-35. [DOI: 10.1517/13543770802691085] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
19 Grosicki M, Adami M, Micheloni C, Głuch-Lutwin M, Siwek A, Latacz G, Łażewska D, Więcek M, Reiner-Link D, Stark H, Chlopicki S, Kieć-Kononowicz K. Eosinophils adhesion assay as a tool for phenotypic drug screening - The pharmacology of 1,3,5 - Triazine and 1H-indole like derivatives against the human histamine H4 receptor. Eur J Pharmacol 2021;890:173611. [PMID: 33017589 DOI: 10.1016/j.ejphar.2020.173611] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Alvarez A, Ibiza MS, Andrade MM, Blas-García A, Calatayud S. Gastric antisecretory drugs induce leukocyte-endothelial cell interactions through gastrin release and activation of CCK-2 receptors. J Pharmacol Exp Ther 2007;323:406-13. [PMID: 17652263 DOI: 10.1124/jpet.107.122754] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
21 Holden NS, Gong W, King EM, Kaur M, Giembycz MA, Newton R. Potentiation of NF-kappaB-dependent transcription and inflammatory mediator release by histamine in human airway epithelial cells. Br J Pharmacol 2007;152:891-902. [PMID: 17891168 DOI: 10.1038/sj.bjp.0707457] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
22 Nagarajan G, Mariappanadar V, Tamizh M, Kaliappan I, Elden BT. Effect of H4R antagonist N -(2-aminoethyl)-5-chloro-1 H -indol-2-carboxamides and 5-chloro-2-(piperazin-1-ylmethyl)-1 H -benzimidazole on histamine and 4-methylhistamine-induced mast cell response. Journal of Receptors and Signal Transduction 2017;37:304-13. [DOI: 10.1080/10799893.2016.1247863] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Schneider E, Leite-de-moraes M, Dy M. Histamine, Immune Cells and Autoimmunity. In: Thurmond RL, editor. Histamine in Inflammation. Boston: Springer US; 2010. pp. 81-94. [DOI: 10.1007/978-1-4419-8056-4_9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
24 Kiss R, Kiss B, Könczöl A, Szalai F, Jelinek I, László V, Noszál B, Falus A, Keseru GM. Discovery of novel human histamine H4 receptor ligands by large-scale structure-based virtual screening. J Med Chem 2008;51:3145-53. [PMID: 18459760 DOI: 10.1021/jm7014777] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 5.0] [Reference Citation Analysis]
25 Bhuiyan P, Chen Y, Karim M, Dong H, Qian Y. Bidirectional communication between mast cells and the gut-brain axis in neurodegenerative diseases: Avenues for therapeutic intervention. Brain Res Bull 2021;172:61-78. [PMID: 33892083 DOI: 10.1016/j.brainresbull.2021.04.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
26 Rosethorne EM, Charlton SJ. Agonist-biased signaling at the histamine H4 receptor: JNJ7777120 recruits β-arrestin without activating G proteins. Mol Pharmacol 2011;79:749-57. [PMID: 21134907 DOI: 10.1124/mol.110.068395] [Cited by in Crossref: 88] [Cited by in F6Publishing: 84] [Article Influence: 7.3] [Reference Citation Analysis]
27 Maintz L, Schwarzer V, Bieber T, van der Ven K, Novak N. Effects of histamine and diamine oxidase activities on pregnancy: a critical review. Hum Reprod Update 2008;14:485-95. [PMID: 18499706 DOI: 10.1093/humupd/dmn014] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 3.9] [Reference Citation Analysis]
28 Bodensteiner J, Baumeister P, Geyer R, Buschauer A, Reiser O. Synthesis and pharmacological characterization of new tetrahydrofuran based compounds as conformationally constrained histamine receptor ligands. Org Biomol Chem 2013;11:4040. [DOI: 10.1039/c3ob40441b] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
29 Weaver JL, Zhang J, Knapton A, Miller T, Espandiari P, Smith R, Gu YZ, Snyder RD. Early events in vascular injury in the rat induced by the phosphodiesterase IV inhibitor SCH 351591. Toxicol Pathol 2010;38:738-44. [PMID: 20585143 DOI: 10.1177/0192623310374331] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
30 Mahdy AM, Webster NR. Histamine and antihistamines. Anaesthesia & Intensive Care Medicine 2008;9:324-8. [DOI: 10.1016/j.mpaic.2008.04.016] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
31 Levoin N, Labeeuw O, Billot X, Calmels T, Danvy D, Krief S, Berrebi-Bertrand I, Lecomte JM, Schwartz JC, Capet M. Discovery of nanomolar ligands with novel scaffolds for the histamine H4 receptor by virtual screening. Eur J Med Chem 2017;125:565-72. [PMID: 27718472 DOI: 10.1016/j.ejmech.2016.09.074] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
32 Whittle BJ, Varga C, Berko A, Horvath K, Posa A, Riley JP, Lundeen KA, Fourie AM, Dunford PJ. Attenuation of inflammation and cytokine production in rat colitis by a novel selective inhibitor of leukotriene A4 hydrolase. Br J Pharmacol 2008;153:983-91. [PMID: 18157165 DOI: 10.1038/sj.bjp.0707645] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
33 Leonardi A, Di Stefano A, Vicari C, Motterle L, Brun P. Histamine H4 receptors in normal conjunctiva and in vernal keratoconjunctivitis. Allergy 2011;66:1360-6. [PMID: 21545429 DOI: 10.1111/j.1398-9995.2011.02612.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
34 Slavchev IM, Mitrev Y, Shivachev B, Valcheva V, Dogonadze M, Solovieva N, Vyazovaya A, Mokrousov I, Link W, Jiménez L, Cautain B, Mackenzie TA, Portugal I, Lopes F, Capela R, Perdigão J, Dobrikov GM. Synthesis, Characterization and Complex Evaluation of Antibacterial Activity and Cytotoxicity of New Arylmethylidene Ketones and Pyrimidines with Camphane Skeletons. ChemistrySelect 2022;7. [DOI: 10.1002/slct.202201339] [Reference Citation Analysis]
35 Jemima EA, Prema A, Thangam EB. Functional characterization of histamine H4 receptor on human mast cells. Molecular Immunology 2014;62:19-28. [DOI: 10.1016/j.molimm.2014.05.007] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 6.1] [Reference Citation Analysis]
36 Raja D, Philips A, Sundaramurthy D, Chandru Senadi G. Sustainable Synthesis of 2-Hydroxymethylbenzimidazoles using D-Fructose as a C2 Synthon. Chem Asian J 2021;16:3754-9. [PMID: 34549532 DOI: 10.1002/asia.202100972] [Reference Citation Analysis]
37 Rodríguez Sarmiento RM, Nettekoven MH, Taylor S, Plancher J, Richter H, Roche O. Selective naphthalene H3 receptor inverse agonists with reduced potential to induce phospholipidosis and their quinoline analogs. Bioorganic & Medicinal Chemistry Letters 2009;19:4495-500. [DOI: 10.1016/j.bmcl.2009.03.100] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
38 Damaj BB, Becerra CB, Esber HJ, Wen Y, Maghazachi AA. Functional Expression of H4 Histamine Receptor in Human Natural Killer Cells, Monocytes, and Dendritic Cells. J Immunol 2007;179:7907-15. [DOI: 10.4049/jimmunol.179.11.7907] [Cited by in Crossref: 76] [Cited by in F6Publishing: 72] [Article Influence: 5.1] [Reference Citation Analysis]
39 Liu J, Li Y, Zhang HX, Zhang SW, Yang L. Studies of H4R antagonists using 3D-QSAR, molecular docking and molecular dynamics. J Mol Model 2012;18:991-1001. [PMID: 21647664 DOI: 10.1007/s00894-011-1137-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
40 Savall BM, Gomez L, Chavez F, Curtis M, Meduna SP, Kearney A, Dunford P, Cowden J, Thurmond RL, Grice C, Edwards JP. Tricyclic aminopyrimidine histamine H4 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 2011;21:6577-81. [DOI: 10.1016/j.bmcl.2011.08.014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
41 Kiss R, Keserű GM. Virtual Screening on Homology Models. In: Sotriffer C, editor. Virtual Screening. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA; 2011. pp. 381-410. [DOI: 10.1002/9783527633326.ch14] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
42 Lane CA, Hay D, Mowbray CE, Paradowski M, Selby MD, Swain NA, Williams DH. Synthesis of novel histamine H4 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 2012;22:1156-9. [DOI: 10.1016/j.bmcl.2011.11.098] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
43 Novak N, Mete N, Bussmann C, Maintz L, Bieber T, Akdis M, Zumkehr J, Jutel M, Akdis C. Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2. J Allergy Clin Immunol 2012;130:1153-1158.e2. [PMID: 22698521 DOI: 10.1016/j.jaci.2012.04.039] [Cited by in Crossref: 86] [Cited by in F6Publishing: 73] [Article Influence: 8.6] [Reference Citation Analysis]
44 Mowbray CE, Bell AS, Clarke NP, Collins M, Jones RM, Lane CA, Liu WL, Newman SD, Paradowski M, Schenck EJ, Selby MD, Swain NA, Williams DH. Challenges of drug discovery in novel target space. The discovery and evaluation of PF-3893787: A novel histamine H4 receptor antagonist. Bioorganic & Medicinal Chemistry Letters 2011;21:6596-602. [DOI: 10.1016/j.bmcl.2011.07.125] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
45 Dandekar RD, Khan MM. Involvement of histamine receptors in SAPK/JNK phosphorylation. Int Immunopharmacol 2012;13:190-6. [PMID: 22487127 DOI: 10.1016/j.intimp.2012.03.023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
46 Roche O, Nettekoven M, Vifian W, Sarmiento RMR. Refinement of histamine H3 ligands pharmacophore model leads to a new class of potent and selective naphthalene inverse agonists. Bioorganic & Medicinal Chemistry Letters 2008;18:4377-9. [DOI: 10.1016/j.bmcl.2008.06.062] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
47 Al-Mazroua HA, Alomar HA, Ahmad SF, Attia MSA, Nadeem A, Bakheet SA, Alsaad AMS, Alotaibi MR, Attia SM. Assessment of DNA repair efficiency in the inbred BTBR T+tf/J autism spectrum disorder mouse model exposed to gamma rays and treated with JNJ7777120. Prog Neuropsychopharmacol Biol Psychiatry 2019;93:189-96. [PMID: 30959085 DOI: 10.1016/j.pnpbp.2019.04.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
48 Savall BM, Edwards JP, Venable JD, Buzard DJ, Thurmond R, Hack M, Mcgovern P. Agonist/antagonist modulation in a series of 2-aryl benzimidazole H4 receptor ligands. Bioorganic & Medicinal Chemistry Letters 2010;20:3367-71. [DOI: 10.1016/j.bmcl.2010.04.017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
49 Nemeth K, Wilson T, Rada B, Parmelee A, Mayer B, Buzas E, Falus A, Key S, Masszi T, Karpati S. Characterization and function of histamine receptors in human bone marrow stromal cells. Stem Cells. 2012;30:222-231. [PMID: 22045589 DOI: 10.1002/stem.771] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
50 Ahmad SF, Zoheir KM, Abdel-Hamied HE, Alrashidi I, Attia SM, Bakheet SA, Ashour AE, Abd-Allah AR. Role of a histamine 4 receptor as an anti-inflammatory target in carrageenan-induced pleurisy in mice. Immunology 2014;142:374-83. [PMID: 24460575 DOI: 10.1111/imm.12257] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
51 Neumann D. Role of the Histamine H4-Receptor in Bronchial Asthma. Handb Exp Pharmacol 2017;241:347-59. [PMID: 27718056 DOI: 10.1007/164_2016_11] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
52 Pappalardo M, Shachaf N, Basile L, Milardi D, Zeidan M, Raiyn J, Guccione S, Rayan A. Sequential application of ligand and structure based modeling approaches to index chemicals for their hH4R antagonism. PLoS One 2014;9:e109340. [PMID: 25330207 DOI: 10.1371/journal.pone.0109340] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
53 Bordi F, Rivara S, Dallaturca E, Carmi C, Pala D, Lodola A, Vacondio F, Flammini L, Bertoni S, Ballabeni V, Barocelli E, Mor M. Dibasic biphenyl H3 receptor antagonists: Steric tolerance for a lipophilic side chain. European Journal of Medicinal Chemistry 2012;48:214-30. [DOI: 10.1016/j.ejmech.2011.12.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
54 Shan Y, Gao Y, Zhang L, Ma L, Shi Y, Liu X. H4 Receptor Inhibits Lipopolysaccharide-induced NF-κB Activation by Interacting with Tumor Necrosis Factor Receptor-Associated Factor 6. Neuroscience 2019;398:113-25. [PMID: 30528857 DOI: 10.1016/j.neuroscience.2018.11.050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
55 Marson CM. Targeting the Histamine H 4 Receptor. Chem Rev 2011;111:7121-56. [DOI: 10.1021/cr900166w] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
56 Masłowska-Lipowicz I, Walczyński K. Structure-activity relationships of new 1-substitutedmethyl-4-[5-(N-methyl-N-propylamino)pentyloxy]piperidines and selected 1-[(N-substituted-N-methyl)-3-propyloxy]-5-(N-methy-l-N-propyl)-pentanediamines as H3 -antagonists. Chem Biol Drug Des 2014;83:106-18. [PMID: 23957330 DOI: 10.1111/cbdd.12206] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
57 Vasicek O, Lojek A, Jancinova V, Nosal R, Ciz M. Role of histamine receptors in the effects of histamine on the production of reactive oxygen species by whole blood phagocytes. Life Sciences 2014;100:67-72. [DOI: 10.1016/j.lfs.2014.01.082] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
58 Engelhardt H, de Esch IJ, Kuhn D, Smits RA, Zuiderveld OP, Dobler J, Mayer M, Lips S, Arnhof H, Scharn D, Haaksma EE, Leurs R. Detailed structure–activity relationship of indolecarboxamides as H4 receptor ligands. European Journal of Medicinal Chemistry 2012;54:660-8. [DOI: 10.1016/j.ejmech.2012.06.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
59 Desmadryl G, Gaboyard-Niay S, Brugeaud A, Travo C, Broussy A, Saleur A, Dyhrfjeld-Johnsen J, Wersinger E, Chabbert C. Histamine H4 receptor antagonists as potent modulators of mammalian vestibular primary neuron excitability. Br J Pharmacol 2012;167:905-16. [PMID: 22624822 DOI: 10.1111/j.1476-5381.2012.02049.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 4.7] [Reference Citation Analysis]
60 Sulaiman I, Lim JC, Soo HL, Stanslas J. Molecularly targeted therapies for asthma: Current development, challenges and potential clinical translation. Pulm Pharmacol Ther 2016;40:52-68. [PMID: 27453494 DOI: 10.1016/j.pupt.2016.07.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
61 Bongers G, de Esch I, Leurs R. Molecular Pharmacology of the Four Histamine Receptors. In: Thurmond RL, editor. Histamine in Inflammation. Boston: Springer US; 2010. pp. 11-9. [DOI: 10.1007/978-1-4419-8056-4_2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
62 Thurmond RL, Greenspan A, Radziszewski W, Xu XL, Miao Y, Chen B, Ge T, Zhou B, Baker DG, Pavlova D, Ritchlin CT, Tanaka Y, Takeuchi T, Smolen JS. Toreforant, A Histamine H4 Receptor Antagonist, in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results of 2 Phase II Studies. J Rheumatol 2016;43:1637-42. [DOI: 10.3899/jrheum.160164] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
63 Davenas E, Rouleau A, Morisset S, Arrang JM. Autoregulation of McA-RH7777 hepatoma cell proliferation by histamine H3 receptors. J Pharmacol Exp Ther 2008;326:406-13. [PMID: 18474684 DOI: 10.1124/jpet.107.135368] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
64 Blandina P, Munari L, Giannoni P, Mariottini C, Passani MB. Histamine neuronal system as a therapeutic target for the treatment of cognitive disorders. Future Neurology 2010;5:543-55. [DOI: 10.2217/fnl.10.30] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
65 Peters LJ, Kovacic JP. Histamine: metabolism, physiology, and pathophysiology with applications in veterinary medicine. J Vet Emerg Crit Care (San Antonio) 2009;19:311-28. [PMID: 25164630 DOI: 10.1111/j.1476-4431.2009.00434.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
66 Sterle HA, Nicoud MB, Massari NA, Táquez Delgado MA, Herrero Ducloux MV, Cremaschi GA, Medina VA. Immunomodulatory role of histamine H4 receptor in breast cancer. Br J Cancer 2019;120:128-38. [PMID: 29988113 DOI: 10.1038/s41416-018-0173-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
67 Rutherford K, Parson WW, Daggett V. The histamine N-methyltransferase T105I polymorphism affects active site structure and dynamics. Biochemistry 2008;47:893-901. [PMID: 18154359 DOI: 10.1021/bi701737f] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]